NINDS Blueprint Neurotherapeutics Network (BPN) extended the ordering period of four (4) existing Indefinite Delivery, Indefinite Quantity (IDIQ) contracts awarded under the BPN Preclinical Testing and Toxicology Program (PTTP), with the contractors listed below. This action extends the ordering period by one year, from September 13, 2026, through September 12, 2027. This is a no-cost modification; no other changes to the contracts' terms, conditions, scope, or ceiling value are being made. SRI International HHSN271201600006I Southern Research HHSN271201600007I IIT Research Institute (IITRI) 75N95021D00026 University of Illinois Chicago, Toxicology Research Laboratory (TRL) 75N95022D00026 Please refer to the attached justification for additional information.
Go deeper on this solicitation
FedSift reads the full solicitation package — every attachment — and pre-extracts the compliance matrix, evaluation factors, key risks, win themes and deal-breakers, each with a verbatim quote and the exact PDF page it came from. It scores the opportunity against your company profile, tells you whether to bid as prime or sub, and ranks teaming partners who could close your gaps.
Source: this notice on SAM.gov. FedSift republishes public federal procurement data and is not affiliated with the U.S. Government. Always confirm dates and requirements against SAM.gov before responding.
